Arenas J, Huertas R, Campos Y, Diaz AE, Villalon JM, Vilas E
CDSCO Advisory May 2026 India's CDSCO issued a public notice on May 18, 2026 placing injectable glutathione drips under regulatory scrutiny
It begins at a dose of 0.25 mg/week in the first 4 weeks, then the subject raises the dose every 4 weeks up to a maintenance dose of 2.4 mg/week
This may be related to reduced caloric intake, changes in blood sugar patterns, or direct effects on the central nervous system
Ranked by 2024 Sales: 1
Liposomal technology addresses the absorption challenge that has historically limited the potential of glutathione supplementation, making it a more viable option for those seeking antioxidant support